Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Study of Proinsulin (PI) Peptide Immunotherapy in New-Onset Type 1 Diabetes

NCT01536431 is registered in ClinicalTrials.gov with Cardiff University as lead sponsor.

NCT NCT01536431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01536431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Study of Proinsulin (PI) Peptide Immunotherapy in New-Onset Type 1 Diabetes
Lead sponsor
Cardiff University
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2012
Completion date
February 28, 2015
Enrollment
27 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes